feaSibility studies for a phototherapy Mask to treAt dry aGe related Macular degenerAtion (MAGMA)

Lead Participant: Polyphotonix Limited


Polyphotonix is working with University College London to understand how the delivery of photonic treatments to the eyes can treat the condition known as Dry Age Related Macular Degeneration. In this project a feasibility study will be carried out in order to define the dose required for efficatious treatment of the condition and also a delivery method will be investgated. By the end of the feasibility study, a delivery method, will have been designed and proof of concept systems will have been fabricated and discussed with focus user groups including Opthamologists, AMD/blindness charities and possible end users. It is planned that the work carried out in this project will be carried on to subsequant clinical trials in order to move the technology to market and gain the required approvals for providing this treatment on the NHS or with healthcare providers Worldwide.

Lead Participant

Project Cost

Grant Offer

Polyphotonix Limited, SEDGEFIELD £121,987 £ 91,490


University College London, United Kingdom £52,400 £ 52,400


10 25 50